Medical and Pharma Insider

MedNews: XII MEDICAL closes $45 million financing to advance its neuromodulation therapy for obstructive sleep apnea Omega Funds and Intuitive Ventures join top-tier syndicate of healthcare investors to support ongoing clinical activities https://wix.to/2feLtia MedNews is a service of Medical and Pharma Insider and FC Global Strategies Medical and Pharma Insider website: https://lnkd.in/egjPED62 FC Global Strategies website: https://lnkd.in/gw9Phwm8 #mednews #xiimedical #omegafunds #mednews #fcglobalstrategies #medicalandpharmainsider

MedNews: EHE Health, the leader in employer-based preventive healthcare is acquired by Consello Capital EHE Health is a national healthcare provider network and center of excellence in preventive health that partners with mid- and large-sized employers to give their employees and beneficiaries an entry point to organized healthcare, beginning with prevention https://wix.to/cXAyeV7 MedNews is a service of Medical and Pharma Insider, an FC Global Strategies company Medical and Pharma Insider website: https://lnkd.in/gtZtsJFe FC Global Strategies website: https://lnkd.in/gw9Phwm8 #consello #ehehealth #mednews #medicalandpharmainsider #mednews #fcglobalstrategies

MedNews: Cyclotron technology innovator and isotope manufacturer IONETIX closes financing led by Tees River and Eli Lilly and Company Utilizing its proprietary cyclotron technology platform, IONETIX has developed innovative solutions that enable access to scarce radioisotopes used for both diagnostic and therapeutic radiopharmaceuticals. https://wix.to/0yEEGL1 #newblogpost

MedNews: Clinical biopharmaceutical company Sellas Life Sciences, focused on the development of novel therapies for a broad range of cancer indications, raises $21 million SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. SELLAS’ other lead product candidate, GPS, is licensed from Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is present in an array of tumor types. https://wix.to/75r94Fn MedNews is a program of Medical and Pharma Insider, an FC Global Strategies company. ` Medical and Pharma Insider website: https://lnkd.in/gtZtsJFe FC Global Strategies website: https://lnkd.in/gw9Phwm8 #sellaslifesciences #cancer #mednews #https://lnkd.in/gtZtsJFe #sellaslifesciences #cancer #mednews #https://lnkd.in/gtZtsJFe

MedNews: AI-enabled biotechnology company ReviR Therapeutics raises $30 million to advance oral genetic medicines for multiple CNS disorders The company is utilizing cutting-edge technologies to develop therapies with the goal of developing disease modifying therapies that are highly specific, efficacious, and safe. MedNews is a service of Medical and Pharma Insider, an FC Global Strategies company Medical and Pharma Insider website: https://lnkd.in/gtZtsJFe FC Global Strategies website: https://lnkd.in/gw9Phwm8 https://wix.to/K8OnZhd #revir #revirtherapeutics #cns #ai #mednews #medicalandpharmainsider

MedNews: ReShape Lifesciences, a weight loss and metabolic health-solutions company to merge with clinical stage specialty pharmaceutical company Vyome, and acquire assets of metabolic health Biorad Medisys Updated: 16 minutes ago Vyome Therapeutics, Inc. is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need with next-generation therapeutic solutions Biorad Medisys Pvt Ltd® is a rapidly growing med-tech company dedicated to redefining healthcare standards with precision-engineered medical devices backed by rigorous scientific research. The Company operates three business units – Indovasive, Orthovasive and Neurovasive. ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, https://wix.to/HmJseDh Medical and Pharma Insider is the sponsor of Medical and Pharma insider a servce of FC GLobal Strategies Medical and Pharma Insider website: https://medicalandpharmainsider,com FC Global Strategies webite : https://lnkd.in/gw9Phwm8 Medical and Pharrma Insider website Https://medicalandpharmainsider

ReShape Lifesciences, a weight loss and metabolic health-solutions company to merge with clinical stage specialty pharmaceutical company Vyome, and acquire assets of metabolic health Biorad Medisys Vyome Therapeutics, Inc. is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need with next-generation therapeutic solutions. Biorad Medisys Pvt Ltd® is a rapidly growing med-tech company dedicated to redefining healthcare standards with precision-engineered medical devices backed by rigorous scientific research. The Company operates three business units – Indovasive, Orthovasive and Neurovasive. ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, https://wix.to/dR9vJSb MedNews is a service of Medical and Pharma Insider, an FC Global Strategies company Medical and Pharma Insider website: https://lnkd.in/gtZtsJFe FC Global Strategies website https://lnkd.in/gw9Phwm8 #reshapelifesciences #vyometherapeutics #bioradmedisys #mednews #medicalandpharmainsider #fcglobalstrategies.com

MedNews: Adult stem cell therapeutics developer BrainStorm Cell Therapeutics (Nasdaq: BCLI) raises $4 million BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases https://wix.to/KHO7Wgy MedNews is a service of Medical and Pbarma Insider, a service of FC Global Strategies . Medical and Pharma Insider website: https://lnkd.in/gtZtsJFe FC Global Strategies website: https;//fcglobalstrategies.com #brainstorm #mednews #medicalandpharmainsider

MedTalks - An interview with Brian Frenzel, CEO of TOSK discussing the company's business and its investment opportunities Tosk has developed and patented two important side-effect-blocking agents, TK-90 for mucositis and pulmonary fibrosis, and TK-39 for cardiotoxicity. Sponsored by NIH SBIR grants, Tosk has also identified oncogenic KRAS-inhibiting drug candidates. These are being developed to treat KRAS-positive malignancies, including 90% of pancreatic, 45% of colon, and 35% of lung cancers. https://wix.to/kTy2wOB #tosk #familyofficeconnector #opportunityspotlight #medicalandpharmainsider #fcglobalstrategies

MedNews: Holoclara closes $16 Million financing to advance worm-derived therapies for allergic and autoimmune disease Financing led by BOLD Capital Partners, alongside early investments from Horizons Ventures and participation from a syndicate of leading angel investors in the life sciences Capital to support clinical development of first-in-class, worm-derived medicines for allergies and autoimmune disorders and advancement of discovery engine https://wix.to/ojH89OB MedNews is a service of Medical and Pharma Insider, an FC Global Strategies Medical and Pharma Insider website: https://medicalandpharmainsidercom FC Global Strategies website: https://fcglobalstrategies;com #holoclara #therapeutics #mednews #medicalandpharmainsider